IMITREX - 0173-0449-02 - (sumatriptan succinate)

Alphabetical Index


Drug Information of IMITREX

Product NDC: 0173-0449
Proprietary Name: IMITREX
Non Proprietary Name: sumatriptan succinate
Active Ingredient(s): 6    mg/.5mL & nbsp;   sumatriptan succinate
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): INJECTION
Coding System: National Drug Codes(NDC)

Labeler Information of IMITREX

Product NDC: 0173-0449
Labeler Name: GlaxoSmithKline LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020080
Marketing Category: NDA
Start Marketing Date: 19930223

Package Information of IMITREX

Package NDC: 0173-0449-02
Package Description: 5 VIAL in 1 CARTON (0173-0449-02) > .5 mL in 1 VIAL

NDC Information of IMITREX

NDC Code 0173-0449-02
Proprietary Name IMITREX
Package Description 5 VIAL in 1 CARTON (0173-0449-02) > .5 mL in 1 VIAL
Product NDC 0173-0449
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name sumatriptan succinate
Dosage Form Name INJECTION
Route Name SUBCUTANEOUS
Start Marketing Date 19930223
Marketing Category Name NDA
Labeler Name GlaxoSmithKline LLC
Substance Name SUMATRIPTAN SUCCINATE
Strength Number 6
Strength Unit mg/.5mL
Pharmaceutical Classes Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]

Complete Information of IMITREX


General Information